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Background: Self-assembling protein nanotubes (PNTs) are an intriguing alternative to carbon nanotubes for
applications in bionanotechnology, in part due to greater inherent biocompatibility. The type IV pilus of the gram
negative bacteria Pseudomonas aeruginosa is a protein-based fibre composed of a single subunit, the type IV pilin.
Engineered pilin monomers from P. aeruginosa strain K122-4 (ΔK122) have been shown to oligomerize into PNTs
both in solution and at surfaces. In order to fully exploit PNTs in bionanotechonological settings, an in-depth
understanding of their assembly, physical characteristics and robustness, both in solution and when constrained to
surfaces, is required.
Results: This study details the effectiveness of multiple initiators of ΔK122-derived PNT oligomerization and
characterize the formation of PNTs in solution. The optimal initiator for the oligomerization of ΔK122 in solution
was observed to be 2-methyl-2,4-pentanediol (MPD). Conversely, larger PEG molecules do not trigger
oligomerization. Multi-angle light scattering analysis indicates that the pilin protein exists in a monomer-dimer
equilibrium in solution, and that an intermediate species forms within three hours that then coalesces over time
into high molecular weight PNTs. Transmission Electron Microscopic analysis was used to observe the formation
of oligomerized ΔK122 fibrils prior to assembly into full-length PNTs.
Conclusions: The oligomerization of ΔK122 pilin derived PNTs is a fibril mediated process. The optimal trigger for
PNT oligomerization in solution is MPD, and the observation that PEGs do not induce oligomerization may enable
the oligomerization of pilin-derived PNTs on PEG-functionalized surfaces for implantable bionanodevices.
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The development of peptide and protein-based na-
notubes as biologically accepted nanosystems have sev-
eral advantages when compared to their inorganic
counterparts such as carbon nanotubes (CNTs), which
are significantly more cytotoxic and present biocompati-
bility issues [1-11]. Peptide and protein based nanotubes
can be assembled utilizing both template and non-
template assembly mechanisms under milder conditions
(ambient temperature, physiological pH), and provide a
readily customizable system via modern protein engin-
eering methods [12,13]. In addition, studies have shown
that wormlike, filamentous nanoparticles are better than* Correspondence: audette@yorku.ca
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reproduction in any medium, provided the orspherical ones at avoiding immune responses allowing
for longer circulation times due to the difficulty of
macrophages have adjusting tertiary and/or quaternary
structure to engulf such elongated particles [14-16].
Therefore, peptide and protein-based nanotubes will
likely have applications as drug-delivery vehicles as their
relatively large inner cavity and high surface areas would
enable them to transport drug molecules, nucleic acids
or antigens to targeted cell surface.
Several recent studies have examined the applicability
of nanotubes from peptides [17-20], proteins [21-29],
and viruses [30-38]. For instance, the mutation of the
pIII and pVII coat proteins of the M13 phage enabled
the modified phage to scaffold metal oxides [34,35]. The
resultant protein-metal hybrid bionanowires demon-
strated significant initial and reversible storage capacity
[35,38], suggesting the utility of these nanocomposites
for power generating applications. Another system ex-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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based on the bacterial flagella, where the flagellin protein
FliC has been modified to contain a thioredoxin domain
[21]. The resultant FliC-thioredoxin chimera was shown
to form PNTs on surfaces [22] as well as enable metal
nanowire synthesis [39]. These studies highlight the
applicability of using bio-inspired PNTs for various
applications in nanoelectronics and as biosensors.
In addition to protein-based nanostructures derived
from viral coat proteins and flagella, PNTs have been
shown to assemble from an engineered form of the type
IV pilin [23,24], the monomeric unit of the type IV pilus
(T4P) of many gram-negative bacteria including Pseu-
domonas aeruginosa. Opportunistic infections by P.
aeruginosa are a significant cause morbidity and mortality
in individuals with compromised immune systems
(e.g. burn victims [40] and cystic fibrosis patients [41]),
with infections being initiated through interaction of T4P
with cellular receptors [42-47]. In addition to cellular
adherence, T4P are involved in a number of functions
including surface adherence [48,49], twitching motility
[47,50-54], DNA uptake [55-57], and biofilm formation
[47,58-60]. T4P are robust structures assembled and
disassembled via a membrane-spanning complex whose
architecture is evolutionarily related to a type II secretion
system [47,50,60]. P. aeruginosa T4P have also been
demonstrated to retract at rates of 0.5-1 μm s-1 (~1500
subunits s-1) [51] generating forces exceeding 100 pN
[61]. The T4P has an outer diameter of approximately 6–8
nm and can reach lengths up to tens of microns
[44,46,47,50,62-65]. T4P are polymers of the type IV pilin,
and cryo-EM [66-68] and fibre diffraction [69] analyses of
T4P have demonstrated that T4P exhibit a three-start
helical assembly of pilin monomers [44,62]. The type IV
pilin monomer is comprised of a four-stranded antiparallel
β-sheet wrapped around a hydrophobic α-helix connected
by a variable loop region [66,70-76]. Surface adherence
and cell-host adhesion is mediated by a C-terminal loop
known as the D-region, which is disulfide-bound in
most pilins [66,68,70-74,76], although the FimA pilin
of Dichelobacter nodosus displays a conserved struc-
ture without the disulfide bond [75]. The observation
that truncated pilins from P. aeruginosa strain K122-4
(ΔK122) could form PNTs morphologically similar to
T4P in the presence of a hydrophobe (C11-SH), both in
solution and when the hydrophobe was surface con-
strained [23,24], presents an interesting avenue for the de-
velopment of bionano applications that target the T4P, for
example pilus-specific biosensors.
Several studies highlight the potential applications of
PNTs including targeted drug delivery systems, tissue-
engineering scaffolds and biosensing devices [35,38,77-83].
However, reports characterizing the assembly and proper-
ties of PNTs generated from full-length proteins in solutionor at surfaces are more limited; it is in this light that we
undertook the characterization of the oligomerization of
pilin-derived PNTs in solution. Pilin-derived PNTs may
have an advantage of being a more biologically accepted
nanosystem when compared to their CNT counterparts.
However in order to fully exploit PNTs for application
development, a detailed understanding of their assembly
and physical characteristics in solution and when surface-
constrained is required. In the current study, we examine
the assembly of ΔK122-derived PNTs in solution, moni-
toring PNT oligomerization through liquid chromatog-
raphy, multi-angle light scattering and negatively stained
transmission electron microscopic methods. We identify
an optimal trigger molecule, 2-methyl-2,4-pentanediol
(MPD), characterize pilin oligomerization in solution, and
discuss the assembly of ΔK122-derived PNTs through
intermediate pilin fibrils.
Results and discussion
The identification that monomeric pilins from P. aeru-
ginosa oligomerized into PNTs [12,13,23] suggests that
these structures could be adapted for a variety of applica-
tions. Previous studies, employing a polyclonal antibody
that recognizes the C-terminal region of the pilin from
multiple strains of P. aeruginosa [84-86], have shown that
the structure of and receptor binding properties of ΔK122
are unaffected upon oligomerization into PNTs [23,48,55].
Furthermore, the observation that pilin-derived PNTs can
assemble both in solution [23] and at surfaces [24,49] sug-
gests that these structures could be adapted for applica-
tions such as biosensors and in bionanoelectronics while
retaining several functional features associated with the
native pilus itself.
Initial studies of pilin-derived PNTs in solution dem-
onstrated that PNTs could be formed in the presence of
long chain alkylthiols [23], and are stable in various
aqueous buffers [23,48,49,55]. Surface studies have fur-
ther demonstrated that longer chain alkanes are required
for PNT oligomerization, although the hydrophobe is
not incorporated into the PNT itself [23,24,49,87]. How-
ever, initial evidence suggested that smaller alkyl-chains
could induce PNT oligomerization (GFA, unpublished
observations). In order to assess the minimal hydro-
phobe required to initiate PNT oligomerization, freshly
purified ΔK122 (15 mg⋅mL-1) was incubated with a
series of trigger molecules for 96 hours and analyzed
using size exclusion chromatography (SEC). Each trigger
molecule's ability to initiate PNT oligomerization was
interrogated via the presence and height of the void vol-
ume peak relative to that of the ΔK122 peak (Figure 1).
PNT oligomerization is triggered by the "hydrophobic"
component of the solution and not due to exposure to
polypropylene of the microcentrifuge tubes during incu-
bation or by buffer components themselves. When
Figure 1 The effect of hydrophobic trigger molecules on PNT oligomerization in solution. SEC analysis (Sephadex G50 resin) of 15 mg⋅mL-1
ΔK122 incubated for 96 hours at room temperature with the addition of: (A) buffer only (10 mM Tris, 300 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.4; no
additives); (B) the hydrophobic trigger solution as reported by Audette et al. (1-undecanethiol, 1-propanol, methanol, DTT, EDTA, pH 6.4) [23]; panels C
through I are buffer with the addition of 1-undecanethiol (C), 1-tetradecanethiol (D), methanol (E), 1-propanol (F), 2-methyl-2,4-pentanediol (G) and
PEG 3350 (H) or PEG 8000 (I). All chromatograms are on a common vertical scale, and the effectiveness of each compound to initiate pilin
oligomerization was evaluated by the appearance of the high molecular weight peak indicated with an arrow in each panel versus the concurrent
decrease in the peak associated with the ΔK122 monomer (panel A).
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tein peak is observed (Figure 1A). Comparatively, when
incubated with the original "hydrophobe solution", a sig-
nificant PNT peak is observed (Figure 1B). As expected,
when incubated with either 1-undecanethiol (Figure 1C)
or 1-tetradecanethiol (Figure 1D) alone in buffer, PNT
oligomerization is observed. However, in both cases,
PNT oligomerization is less than that observed when
comparing to the original hydrophobe solution (Figure 1B).
This is likely due to the low solubility of both C11-SH and
C14-SH. The addition of 1-propanol and methanol in the
original PNT trigger solution greatly increased the aque-
ous solubilisation of the alkylthiol allowing for increased
interaction with the protein, which in turn increased PNT
formation. Interestingly, both methanol (Figure 1E) and 1-
propanol (Figure 1F) alone in buffer were able to trigger
PNT oligomerization. In both cases, the PNT peaks are
larger than those seen with either C11-SH or C14-SH, again
indicating that solubility of the hydrophobic trigger mol-
ecule in the aqueous buffer is critical for initiation of PNT
oligomerization.
The most effective trigger compound for the oligo-
merization of ΔK122 PNTs was found to be 2-methyl-2,4-
pentanediol (MPD) (Figure 1G). MPD had been expectedto behave similarly to 1-propanol in its ability to trigger
PNT oligomerization. This is because the presence of the
second hydroxyl group in MPD increases its hydrophil-
icity despite containing 2 more methylene groups than
propanol. This increased hydrophilicity enables MPD to
more effectively interact with proteins in solution and is
therefore often used in protein crystallization [88]. In fact,
the PNT peak associated with the incubation of ΔK122
with MPD is larger than any of the other samples, both in
peak height as well as its ratio to the monomeric ΔK122-4
peak (Figure 1). This indicates that the added solubility
due to the second hydroxyl of MPD adds sufficient hydro-
philicity for a more favorable interaction with the ΔK122
monomer in order to initiate PNT oligomerization. In
contrast to MPD, exposure of the protein to polyethylene
glycol (PEG) 3350 (Figure 1H) or PEG 8000 (Figure 1I)
shows very little PNT oligomerization. PEGs are also fre-
quently used in protein crystallization [88,89], and have
been shown to reduce non-specific adsorption of proteins
to implantable devices [90]. These data are important for
the future development of PNT-containing nanodevices
where the bio-nonfouling nature of PEG additives as
surface coatings is exploited for increasing implantable
device lifetimes in the body [91]. The lack of PNT
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tionalization of surfaces with PEGs and exposed hydro-
phobes for site-localized PNT oligomerization; we are
currently examining this possibility.
Previous studies of ΔK122 PNT formation [23,87]
showed the appearance of a peak with a retention time
longer than that of the monomeric pilin. A peak with a
longer retention time was also observed when studying
the optimal trigger molecule for PNT oligomerization
(Figure 1). It has been suggested that this longer reten-
tion SEC peak was a result of a ΔK122 pilin fibril that
interacted abnormally with the chromatographic resin
[23]. The presence of a pilin fibril would be consistent
with both initial TEM studies of PNTs, where the PNTs
were observed to "fray" [23], as well as current three-
start T4P assembly models [44,62,67]. In order to clarify
the oligomerization process, and identify this predicted
pilin fibril, we monitored the oligomerization of ΔK122
in solution over time on a high-resolution silica-based
SEC column (Figure 2). Starting with the initial ΔK122
solution (1 mg⋅mL-1), incubation with the MPD initiator
resulted in a decrease in the peak height associated with
the ΔK122 monomer, with a concurrent increase in peak
heights of peaks associated with higher molecular weight
species (Figure 2, Peak 1 vs. Peaks 2 & 3). The presence
of higher molecular weight species (Peaks 2 and 3) can
be observed in as early as 3 hours (brown trace). Com-
parison of relative peak areas indicates that at 3 hoursFigure 2 Monitoring ΔK122 PNT generation over time. SEC analysis (10
oligomerization buffer for 3 hours (brown), 24 hours (red) or 72 hours (gree
the appearance and increase in height of peaks associated with higher mo
peaks were integrated (inset table) to assess PNT oligomerization over time
Table 1) and identified as pilin-derived nanofibrils (Peak 2) and PNTs (Peakincubation, the monomeric form of ΔK122 decreases
from 82.5% to 44.8% total species present, while the
higher molecular weight species increase from 17.5% to
55.1% (Figure 2, inset table). The higher molecular
weight species continue to accumulate over 24 (red
trace) and 72 (green trace) hours, resulting in the higher
molecular weight species accounting for 90% of the total
protein present in solution after 72 hours. Of the
resulting overall 90% total protein, an average of 23.5%
remains in the middle range (Peak 2), suggesting that
the process of PNT oligomerization is likely dependent
upon the initial formation of an intermediate species
(Peak 2) that then form PNTs (Peak 3) over time. It was
also noted that the peak corresponding to the ΔK122
monomer (Peak 1) does not fully disappear over the
process of PNT formation, remaining at ~10% of the
protein present after 72 hours incubation. A possible ex-
planation for this is that there is an equilibrium between
the ΔK122 and nascent fibrils prior to incorporation into
full PNTs.
At incubation times up to 24 hours, the presence of a
shoulder on the high molecular weight SEC peak
(Figure 2; red trace) was noted, suggesting multiple high
molecular weight species were present in solution. To
assess the species present in solution during the assembly
of PNTs from monomeric ΔK122, SEC separated samples
were subjected to multi-angle light scattering (MALS)
analysis following SEC separation (Figure 3A). The proteinnm pore size) of 1 mg⋅mL-1 ΔK122 (blue) incubated with MPD in
n). The peak associated with ΔK122 (Peak 1) decreased over time with
lecular weight species (Peaks 2 and 3). The relative areas of these
. The peaks were further characterized by MALS and TEM (Figure 3;
3).
Figure 3 Characterizing the process of ΔK122 PNT oligomerization in solution. (A) SEC analysis (10 nm pore size) of 1 mg⋅mL-1 ΔK122
before (blue) and after (red) 24 hr incubation with MPD. Peaks 1 through 4 were analyzed with multi-angle light scattering in-line with the SEC
(SEC-MALS; Table 1). SEC-MALS data indicate that ΔK122 exists in a monomer/dimer equilibrium (Peak 1) and that upon incubation with MPD,
higher molecular weight species form, corresponding to 14, 20 and 40 pilin monomers for Peaks 2, 3 and 4, respectively (Table 1). Aliquots of
SEC-separated ΔK122 (15 mg⋅mL-1) incubated with MPD for 24 hr corresponding to Peaks 1/2 and 3/4 were negatively stained with 4% uranyl
acetate and visualized with TEM. (B) The ΔK122 monomer/dimers in Peaks 1/2 are seen as aggregates in TEM, and form pilin fibrils (highlighted
by arrows) upon addition of the oligomerization initiator MPD to the protein solution. (C) Pilin fibrils associate into PNTs (Peaks 3/4), which can
then coalesce into larger PNT bundles that show similar structures as those formed when C11-SH is used as the inducer of pilin oligomerization
[23,87].
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vant MALS data are presented in Table 1. Multiple molar
mass values are reported from MALS experiments, in-
cluding the number-averaged (Mn) and weight-averaged
(Mw) molar mass; the ratio of Mw/Mn (polydispersity
index) is an indication of the heterogeneity of the species
being analyzed [92,93]. When Mw/Mn differs from unity,
the species is a more polydisperse mixture and MW is a
generally more reliable assessment of the molecular mass
of the species present. It can be seen from Table 1 that the
all peaks analyzed (Figure 3A) show Mw/Mn ratios indi-
cating the presence of multiple species in each peak.
Analysis of the peak corresponding to "monomeric"
ΔK122 shows a MALS-determined Mw of 26.5 ± 1.2 kDa
and hydrodynamic radius (Rh) of 4.32 ± 0.11 nm. While
the Rh of the pilin correlates with that known from the
crystallographic structures of the ΔK122 pilin [71], the
MALS-determined Mw was unexpected. Taking into con-
sideration that the known molecular weight of ΔK122 is
12,837.57 Da [94], and that both crystallographically deter-
mined structures of ΔK122 have dimers with their asym-
metric unit [71], these data indicate that the ΔK122 pilin
exists in a monomer-dimer equilibrium prior to initiation
of PNT oligomerization. In addition, electro-spray mass
spectrometric analysis of ΔK122 also suggests a mono-mer-dimer equilibrium and that pilin dimers come to-
gether to form larger species after addition of the MPD
trigger (D. Yong et al., in preparation). Furthermore, not-
ing the generally low solubility of full-length pilins due to
the presence of the hydrophobic N-terminal α-helix
[66,70,75], and that long-standing solutions of ΔK122 ap-
pear to form gels in microfuge tubes (data not shown), the
observation of a monomer-dimer equilibrium of ΔK122 in
solution is not unexpected. SEC-MALS analysis of ΔK122
following 24 hours incubation with MPD shows several
higher molecular weight species present in solution
(Figure 3A, Peaks 2–4; Table 1). The protein species
within these peaks were relatively mobile, with transla-
tional diffusion (Dt) coefficients and Rh values similar to
that observed for the ΔK122 monomer/dimer (Table 1;
Peak 1), however the Mw determined for each peak
suggests that these species are composed of increasing
amounts of ΔK122. With an observed Mw of 183.6 ± 17.4
kDa, the species within Peak 2 (Figure 3A) would contain
fourteen ΔK122 monomers; the species in Peaks 3 and 4
would be composed of approximately twenty and forty
monomers, respectively.
In order to observe the species identified by SEC-
MALS analysis, aliquots of SEC-separated ΔK122 pilin
(15 mg⋅mL-1) after 24 hours incubation with MPD
Table 1 SEC-MALS analysis of ΔK122 oligomerization
Peak 1* Peak 2 Peak 3 Peak 4
Mw (kDa) 26.5 ± 1.2 183.6 ± 17.4 256.7 ± 37.7 520.7 ± 146.3
Mw/Mn 1.11 ± 0.07 1.27 ± 0.22 1.71 ± 0.46 1.16 ± 0.49
Rh (nm) 4.32 ± 0.11 4.20 ± 0.13 3.9 ± 0.1 4.1 ± 0.1
Dt (x10-9
cm2s-1)
5.82 ± 0.15 6.10 ± 0.22 6.6 ± 0.2 6.15 ± 0.2
*Peaks analyzed as indicated in Figure 3A.
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stained with 4% uranyl acetate, visualized with TEM
(Figure 3B, C), and compared to that PNTs oligomerized
using the original C11-SH hydrophobe as the inducer
[23,87]. TEM analysis of a Peak 1/2 aliquot (Figure 3B)
show pilin fibrils (highlighted with arrows) interspersed
among a general aggregation of the ΔK122 monomers/
dimers. The components of a Peak 3/4 aliquot shows
the presence of full PNTs (Figure 3C), consistent with
previous observations of pilin-derived PNTs in solution
[23] and at surfaces [24]. MALS analysis of this Peak 3/4
aliquot was challenging due to the high protein concen-
tration (15 mg⋅mL-1) resulting in signal overload at the
detector. However a MALS-determined Mw of 51,610 ±
4,900 kDa was observed for the species in this SEC-
separated aliquot. This Mw corresponds to a structure that
is microns in length containing ~4040 ΔK122 monomers,
a structure which is observed in the TEM analysis of the
Peak 3/4 aliquot (Figure 3C). Pilin-derived PNTs were also
observed to further bundle into larger structures
where PNT bundles ranging in width from ~25-65
nm (Figure 3C) to greater than 250 nm in cross-
section [95]. Given the predicted outer diameter of ~6 nm
for native T4P [44,46,62,63,66,67,69] and/or K122-derived
PNTs [12,23,24], the observed structures would correspond
to bundles of ~4-11 PNTs.
T4P assembly/disassembly is achieved via a multi-
protein membrane associated complex in a highly coor-
dinated fashion [46,47,50,60,62,64,65,67]. However PNTs
derived from truncated ΔK122 monomers do not have
such a protein system to guide PNT assembly, nor do
they have the conserved N-terminal region of the α-
helix to hydrophobically drive pilin oligomerization. It is
therefore not surprising that multiple species (mono-
mers, dimers, multimers) are present in solution during
PNT oligomerization. Indeed, SEC-MALS analysis of the
MPD-initiated ΔK122 PNT formation (Table 1) shows
that multiple species are present in solution. These mul-
tiple species are difficult to separate chromatographically
as they reach higher molecular weights, however SEC-
MALS data suggests that the species are likely multiples
of dimers (Table 1). In addition, the observation of an
initial ΔK122 monomer/dimer in solution (Figure 3A, B;
Table 1) is not unprecedented knowing that bothcrystallographic structures of ΔK122 show two pilin
molecules within their respective asymmetric units [71].
Upon addition of the MPD trigger to the protein, ΔK122
monomer/dimers would oligomerize into extended fibrils,
which then can come together to form PNTs (Figure 4). If
the ΔK122 PNTs oligomerized via a one-start mechanism
as was initially suggested [23], one would expect ring-like
structures when analyzing the contents of the intermedi-
ate molecular weight species (Figure 2, Peak 2). However a
more extended structure, rather than protein rings, was
observed (Figure 3B) for the intermediate pilin fibrils.
When the pilin fibrils are of sufficient length, they then
coalesce into PNTs that have the characteristic three-start
helical symmetry seen in native T4P (Figure 4) while
retaining the native structure and binding characteristics
of pilins within the T4P [23,48,55]. The exact mechanism
of this fibril coalescence is at this time unclear, however it
may be possible that stabilization of the truncated pilin
dimer and fibril is achieved through involvement of the α-
helix. A comparison of the crystal [71] and NMR [73]
structures of ΔK122 revealed that the α-helix of the pilin
was less tightly packed on the β-sheet of the pilin in the
NMR structure [71], suggesting some flexibility prior T4P
assembly. Noting that there are some arguments in favour
of a less rigid packing of the β-sheet onto the α-helix in
the T4P [96], it is possible that the truncated α-helix of
ΔK122 shifts to increase helix-helix interactions in the
dimer/fibril and thereby impart increased stability to the
nascent fibril prior to coalescence into PNTs. Further-
more, as native T4P are known to bundle on surfaces for
coordinated motion and biofilm formation [47,50,58-60],
the observation that pilin-derived PNTs also further asso-
ciate and form larger bundle-like structures (Figure 3C)
was expected. Research in our lab is ongoing to fully eluci-
date the mechanisms by which the ΔK122 pilin stabilizes
the nascent fibril and to form PNTs, as well as determine
the parameters of PNT bundle formation and identify
how one may isolate a single PNT from a formed bundle
either in solution or at surfaces.
Conclusions
The development of protein-based nanotubes for biologic-
ally based nanosystems is receiving increased interest
due to their richness in structural diversity, adaptability
through protein engineering approaches and inherent
biocompatibility. The adaptation of the T4P as protein
nanotubes through engineered type IV pilin monomers
has shown distinct promise in that these structures can as-
semble both in solution and at surfaces in a template inde-
pendent fashion [23,24,49,87,95]. In the current report, we
have shown that the ΔK122 pilin is in a monomer-dimer
equilibrium in solution, and that oligomerization of the
pilin can be induced from short alkyl chains in solution,
however optimal oligomerization is achieved when MPD
Figure 4 A model of fibril-mediated pilin-derived PNT assembly. The ΔK122 pilin (PDB ID 1QVE) [71] exists in a monomer-dimer equilibrium
in solution. Upon addition of a hydrophobic initiator such as MPD to the protein solution, the ΔK122 pilin forms fibrils that can then assemble
into PNTs through the coalescence of three fibrils in a three-start helical assembly as observed in native T4P [67]. Once formed, PNTs are able to
form bundles (Figure 3C) and retain binding characteristics similar to native T4P [47,50,58-60]. The common structural features of the type IV pilins
are highlighted on the ΔK122 monomer the 4-stranded antiparallel β-sheet (green) that is packed onto a (truncated) N-terminal α-helix (cyan)
and connected by variable loop regions (gold); receptor and surface interactions by the pilins are mediated by the C-terminal D-region
(magenta). The three ΔK122 fibrils that comprise the full pilin-derived PNT are shown in purple, green and blue, respectively.
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MPD initiator to the ΔK122 solution, the protein
forms fibrils that then assemble into full length PNTs
(Figures 2, 3), although the exact assembly mechanism is
at this time unclear. Research in our group is on going to
further characterize ΔK122-derived PNT assembly (both
in solution and at surfaces), understand the structural and
mechanistic requirements of PNT oligomerization and fi-
bril stabilization, and to develop these structures for appli-
cations as bionanowires and biosensors.
Methods
Expression and purification of ΔK122
The truncated form of the monomeric type IV pilin
from P. aeruginosa strain K122-4 [pilA (Δ1-28); ΔK122]
was expressed and purified as previously reported
[23,24,71,94]. The ΔK122 pilin was purified as an MBP-
fusion construct and isolated from the MBP tag via cat-
ion exchange chromatography using a linear gradient of
0–1 M NaCl in 10 mM Tris (pH 7.4) following trypsin
digestion of the MBP-ΔK122 fusion protein (500:1 pro-
tein:trypsin ratio; 10 min on ice). Freshly purified, mono-
meric ΔK122 pilin was concentrated to 15 mg⋅mL-1 or
diluted to 1 mg⋅mL-1 as appropriate and used for all
oligomerization experiments. All experiments conductedin this study were reviewed and approved by the York
University's Biological Safety Committee, the institu-
tional body responsible for oversight of such research.
Determination of an optimal trigger of ΔK122
oligomerization in solution
The initially reported solution for initiating oligomeriza-
tion was composed of 1.1 M 1-undecanethiol (C11-SH)
in methanol containing 1 mM EDTA, 1 mM dithio-
threitol (DTT) at pH 6.4 [23]. Studies of PNT oli-
gomerization from surfaces suggest that the initiation of
PNT assembly could be achieved with smaller chain
alkylthiols, and/or mixtures thereof [24,87]. Characte-
rization of an optimal trigger molecule in solution was
conducted by incubating 15 mg⋅mL-1 ΔK122 with buffer
(10 mM Tris, 300 mM NaCl, 1 mM EDTA, 1 mM DTT,
pH 7.4) alone, or with buffer plus methanol (3.2 M), 1-
propanol (1.7 M), 1-undecanethiol (C11-SH, 0.6 M), 1-
tetradecanethiol (C14-SH, 0.5 M), 2,4-methylpentanediol
(MPD, 1.0 M), polyethylene glycol 3350 (PEG 3350, 6.5%
(w/v)) or polyethylene glycol 8000 (PEG 8000, 6.5%
(w/v)) (Figure 1). PNT oligomerization was initiated
through the addition of the trigger solution to ΔK122 in
a 10:1 (v/v) protein to hydrophobe ratio, and the ΔK122-
trigger solution was incubated at room temperature with
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tored using size exclusion chromatography (SEC) on a
G50 Sephadex column (separation range 1.5 kDa - 30
kDa, standardized with blue Dextran 2000, V0/VTotal =
17.23/49.9l mL) on an Akta Purifier (GE Healthcare) at a
flow rate of 1 mL⋅min-1.
Multi-angle light scattering of ΔK122 oligomerization
The oligomerization of 1 mg⋅mL-1 ΔK122 triggered with
MPD in buffer was analyzed using SEC and multi-angle
light scattering (MALS) using an Akta Purifier 10 (GE
Healthcare) connected in-line to a Dawn Heleos II and
Optilab T-rEX light scattering system (Wyatt Technol-
ogy) (Figure 2, 3). Analysis of 100 μL protein samples
was performed at a flow rate of 0.5 mL min-1 in SEC
buffer (10 mM Tris, pH 7.4) on a silica-based column
(Wyatt Technology, 10 nm pore size, separation range
100 Da - 100 kDa, VTotal = 10.71 mL). After chromato-
graphic separation, the column eluate traveled to the
MALS flow cell where light scattering (658 nm laser
light source) of the separated species was monitored by
15 angularly separated static light scattering detectors
and a quasi-elastic light scattering (QELS) detector at a
collection angle of 100.2º (Figure 3A; Table 1). Hydro-
dynamic radii (Rh) and diffusion coefficients (Dt) were
calculated from an autocorrelation function using the
accompanying Astra 6 software package (Table 1).
Transmission electron microscopy
Transmission electron microscopy (TEM) of SEC-MALS
separated PNTs was conducted in the Department of
Biology’s Core Imaging Facility at York University, and
samples for TEM analysis were prepared as follows. Ten
microlitre aliquots of PNT solutions were dispensed
onto plastic-coated nickel mesh grids and allowed to dry
in air for 10 min; any remaining liquid was carefully
removed by blotting with filter paper. Samples were
stained with a 4% aqueous uranyl acetate, which was
added to the grid and allowed to incubate for 10 minutes
at room temperature, following which excess stain was
removed by blotting with filter paper. Samples were im-
aged using a Philips 210 Transmission Electron Micro-
scope operating at an accelerating voltage of 60 kV, and
images visualized using the ImageJ software package [97].
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